Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Pervin Topcuoglu"'
Autor:
Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Taner Demirer, Gunhan Gurman, Meral Beksac, Osman Ilhan, Muhit Ozcan
Publikováno v:
Balkan Medical Journal, Vol 40, Iss 3, Pp 197-204 (2023)
Background: Allogeneic hematopoietic stem cell transplantation is a well-established approach for patients diagnosed with primary myelofibrosis and remains the only potentially curative treatment. Aims: To present the overall outcome of patients wit
Externí odkaz:
https://doaj.org/article/31bb8173591949c6905e9d512718c6ce
Autor:
Hulya Yilmaz, Guldane Cengiz Seval, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Taner Demirer, Isinsu Kuzu, Meral Beksac, Muhit Ozcan
Publikováno v:
HemaSphere, Vol 7, p e583935d (2023)
Externí odkaz:
https://doaj.org/article/56fc9e5be4f04be6b2b690ccaf9384bd
Autor:
Guldane Cengiz Seval, Ekin Kircali, Derya Koyun, Bulent Karakaya, Hulya Yilmaz, Gul Yavuz, Hakan Akbulut, Selami Kocak Toprak, Pervin Topcuoglu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac
Publikováno v:
HemaSphere, Vol 6, Pp 26-26 (2022)
Externí odkaz:
https://doaj.org/article/08a62f24c8b744be884a7c2ca65375fc
Publikováno v:
Turkish Journal of Hematology, Vol 29, Iss 4, Pp 409-412 (2012)
Currently, Steroid refractory severe gastrointestinal (GI) GVHD is one of the important complications in patients undergoing allogeneic transplantation and there has been no standard therapeutical approach of disease yet. We report here the results r
Externí odkaz:
https://doaj.org/article/67d9c6f27adb4bd8a17ba8297c058769
Autor:
Sinem Civriz Bozdağ, Gülden Bozkurt, Pervin Topcuoglu, Alpay Azap, Muhit Özcan, Nahide Konuk, Önder Arslan
Publikováno v:
Turkish Journal of Hematology, Vol 29, Iss 1, Pp 63-66 (2012)
Clinical course of H1N1 infection in Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) patients is contraversial. We report three AHSCT patients who were infected with Influenza A/H1N1 infection. All of the patients were diagnosed with diffe
Externí odkaz:
https://doaj.org/article/13d4f7c8178d44a1ac64603f8dc22be0
Autor:
Pinar Ataca, Erden Atilla, Pelin Saracoglu, Gulden Yilmaz, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Koray Ceyhan, Pervin Topcuoglu
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Aspergillus thyroiditis is a rare disorder detected in immunocompromised patients during disseminated infections. Early management is essential to prevent high mortality. A 61-year-old allogeneic stem cell male recipient presented with painful thyroi
Externí odkaz:
https://doaj.org/article/a16d0ddabb03440f9e847076570c32d2
Autor:
Zehra Narli Ozdemir, Ekin Kircali, Uğur Şahin, Guldane Cengiz Seval, Sinem Civriz Bozdağ, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Taner Demirer, Osman Ilhan, Meral Beksac, Gunhan Gurman, Muhit Ozcan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:596-600
The benefit of pre-transplant consolidation in patients with acute lymphoblastic leukemia (ALL) who achieved first complete remission (CR1) has not yet been clearly demonstrated. Here, we aimed to investigate the relationship between the treatments r
Autor:
Muhit Ozcan, Osman Ilhan, Ekin Kircali, Meltem Kurt Yuksel, Meral Beksac, Onder Arslan, Gunhan Gurman, Sinem Civriz Bozdag, Klara Dalva, Pervin Topcuoglu, Selami Kocak Toprak, Guldane Cengiz Seval
Publikováno v:
Journal of Ankara University Faculty of Medicine. 74:337-342
Autor:
Meral Beksac, Gunhan Gurman, Meltem Kurt Yuksel, Sinem Civriz Bozdag, Muhit Ozcan, Uğur Şahin, Zehra Narli Ozdemir, Osman Ilhan, Taner Demirer, Pervin Topcuoglu, Onder Arslan, Selami Kocak Toprak
Publikováno v:
Journal of Ankara University Faculty of Medicine. 74:278-282
Autor:
Meral Beksac, Guldane Cengiz Seval, Derya Koyun, Pervin Topcuoglu, Meltem-Kurt Yuksel, Gunhan Gurman, Osman Ilhan
Publikováno v:
Clinical lymphoma, myelomaleukemia.
This study aimed to compare use of original brand-name lenalidomide (Revlimid®) vs. generic equivalent (Rivelime®) in terms of efficacy, safety and survival outcome in patients with relapsed/refractory multiple myeloma (RRMM) PATIENTS AND METHODS: